What is the current market size?

The Sodium Iodide Injection market size reached USD 1.2 billion in 2023, reflecting steady adoption in nuclear imaging and diagnostic procedures.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.8% from 2024 to 2032, driven by rising cancer diagnostics and nuclear medicine advancements.

What are the key drivers of growth?

Key drivers include increased demand for non-invasive diagnostics, expansion of nuclear imaging centers, and rising prevalence of thyroid disorders.

What challenges does the market face?

Challenges include strict regulatory compliance, radioactive material handling risks, and high production costs for radiopharmaceuticals.

Which regions lead the market?

North America dominates the Sodium Iodide Injection market, followed by Europe, due to advanced healthcare infrastructure and high R&D investments.

Who are the top companies?

Leading companies include Lantheus Medical Imaging, Bracco Imaging, and IOPTEMY, focusing on product innovation and strategic partnerships.

What future opportunities exist?

Emerging markets in Asia-Pacific and Latin America present growth opportunities due to improving healthcare access and diagnostic infrastructure.

How does technology impact the market?

Advancements in radiopharmaceutical synthesis and precision imaging technologies enhance the efficacy and safety of Sodium Iodide applications.

What is the regulatory landscape?

Regulatory bodies like FDA and EMA enforce strict quality and safety standards, ensuring compliance with dosimetry and radioactive material handling protocols.

What role does the market play in healthcare?

Sodium Iodide Injection is critical in diagnosing thyroid and cardiac conditions, supporting early detection and personalized treatment strategies.

Sodium Iodide Injection Growth Trends & Strategic Outlook 2033

Sodium Iodide Injection by Application (Hospital, Clinic, Others), by Types (Sodium Iodide I-131 Injection, Sodium Iodide I-123 Injection), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Sodium Iodide Injection Market Size | CAGR 7.2 Forecast 2033

Sodium Iodide Injection Growth Trends & Strategic Outlook 2033

🏭 Healthcare🌍 Global

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Sodium Iodide Injection Market Overview

Sodium Iodide Injection is a radiopharmaceutical agent used in nuclear medicine for diagnostic imaging of the thyroid gland. Its relevance lies in its critical role in diagnosing and monitoring thyroid disorders, including hyperthyroidism and cancer, due to its ability to selectively accumulate in thyroid tissue. The Sodium Iodide Injection market size is projected to reflect steady industry expansion, driven by rising prevalence of thyroid diseases, advancements in nuclear imaging technologies, and growing adoption of non-invasive diagnostic procedures.

The global Sodium Iodide Injection market is valued at USD 145 million in 2025, with a projected growth outlook of 5.8% CAGR through 2033, reaching USD 242 million by 2033. Key market forecast drivers include increasing healthcare expenditure in emerging economies, regulatory approvals for next-generation radiopharmaceuticals, and the shift toward personalized medicine. The market forecast is tempered by supply chain volatility, as iodine-131 production relies on limited global reactor facilities. North America dominates the market due to advanced healthcare infrastructure, while Asia-Pacific is the fastest-growing region, fueled by rising awareness and expanding diagnostic networks. Strategic partnerships among radiopharmaceutical manufacturers and hospital networks are intensifying competitive intensity, further shaping the industry landscape.

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.30 billion
Revenue forecast in 2033	4.01 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Acuity Inc.; Cree Lighting USA LLC.; Samsung Electronics; Signify Holding; OSRAM GmbH; Savant Systems, Inc.; Vakkerlight; Digital Lumens; Jainsons Emporio; Hudson Valley Lighting Group; Tom Dixon; Flos; Louis Poulsen; Bover, S.L.; Vibia
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of thyroid disorders and cancer is fueling demand for diagnostic imaging, directly impacting the Sodium Iodide Injection market size. Advanced applications in nuclear medicine for both diagnostic and therapeutic purposes are further driving adoption, particularly in developed healthcare systems with high screening rates.

Technological advancements in radiopharmaceutical production are enhancing the efficacy and safety profile of Sodium Iodide Injection. Innovations in isotope purification and delivery mechanisms are reducing side effects, improving patient compliance, and expanding the treatment window for chronic conditions.

Restraints2 items

High production costs and supply chain fragility for radioactive isotopes limit scalability. The reliance on cyclotron facilities and specialized raw materials creates bottlenecks, particularly in emerging markets with underdeveloped infrastructure.

Regulatory scrutiny and safety concerns remain significant barriers. Stringent guidelines for handling radioactive substances, coupled with physician hesitancy in regions with limited nuclear medicine expertise, slow market penetration.

Opportunities2 items

Expansion into Asia-Pacific and Latin America offers untapped growth potential as healthcare modernization increases access to diagnostic imaging. Government initiatives to upgrade nuclear medicine facilities in these regions present strategic entry points.

Partnerships with diagnostic imaging centers and hospitals can drive adoption through bundled service models. Customized Sodium Iodide Injection formulations for personalized medicine applications also represent a high-margin niche.

Challenges2 items

Intense competition from alternative radiopharmaceuticals such as Technetium-99m and Iodine-131 pressures pricing and market share. Cost-conscious payers and reimbursement constraints further compress margins.

Supply volatility of Iodine-123 and Iodine-131 due to geopolitical risks in isotope-producing countries (e.g., Canada, Netherlands) disrupts production timelines. This necessitates costly buffer inventories or alternative sourcing strategies.

Market Segmentation

Loading chart…

Application segments in the Sodium Iodide Injection market are defined by clinical use cases. Nuclear Medicine Imaging dominates, accounting for 55% of the total market, driven by its role in diagnosing thyroid disorders and guiding radiation therapy. Thyroid Function Testing constitutes 45%, reflecting its importance in screening and monitoring hyper/hypothyroidism. These applications are mutually reinforcing, with advancements in imaging technology boosting demand for high-purity isotopes. Regional disparities in healthcare infrastructure also influence adoption rates, particularly in emerging markets where diagnostic capabilities are expanding.

Type segments are categorized by isotope variants. I-131 Sodium Iodide holds 65% of the market, valued for its dual role in diagnostics and therapeutic applications, particularly in treating thyroid cancer. I-123 Sodium Iodide commands 35%, preferred for shorter imaging procedures due to its lower radiation exposure. The choice between isotopes hinges on clinical protocols and regulatory frameworks, with I-131 dominating in oncology settings. Supply chain constraints for isotopes, influenced by production facility concentrations, further shape this Sodium Iodide Injection segmentation.

Sodium Iodide Injection Segmentation Breakdown7 items

Application

Hospital

Clinic

Others

Types

Sodium Iodide I-131 Injection

Sodium Iodide I-123 Injection

Regional Insights

Loading chart…

North America leads the Sodium Iodide Injection market, accounting for 35% of global revenue. Robust healthcare infrastructure, high adoption of nuclear medicine for diagnostic imaging, and favorable reimbursement policies drive demand. The aging population and rising radiopharmaceutical investments further bolster growth. Asia-Pacific emerges as the fastest-growing region, with a projected CAGR of 7.8% through 2030, fueled by expanding healthcare access, demographic shifts, and ecosystem maturity in emerging economies.

Regional Drivers and Trends5 items

North America: Policy support for diagnostic innovation, high per capita healthcare spending, and established nuclear medicine facilities.

Europe: Aging demographics, EU-funded research initiatives, and cross-border collaboration in radiopharmaceutical development.

Asia-Pacific: Rising government investments in healthcare infrastructure, growing nuclear medicine training programs, and expanding middle-class access.

Latin America: Increasing adoption of cost-effective diagnostic solutions and improved regulatory frameworks.

Middle East & Africa: Strategic partnerships between global players and local distributors, coupled with public health campaigns to address thyroid disorders.

The Sodium Iodide Injection market growth trajectory underscores a $620M regional forecast by 2030, with Asia-Pacific and North America dominating strategic investments. Policy alignment, ecosystem readiness, and infrastructure scalability remain critical differentiators across regions.

Competitive Landscape

The Sodium Iodide Injection market exhibits a moderately consolidated structure, with a blend of global pharmaceutical firms and regional specialty manufacturers competing on pricing, regulatory approvals, and distribution networks. Key players leverage Sodium Iodide Injection key players status by emphasizing product innovation, such as enhanced radiopharmaceutical formulations, and securing certifications for nuclear medicine applications. Competitive differentiation is further driven by strategic geographic penetration, with multinational firms prioritizing emerging markets and local players capitalizing on cost-competitive manufacturing. Pricing remains a critical lever, though margins are constrained by stringent compliance requirements and reimbursement dynamics.

Strategic priorities among competitors include R&D investment for next-generation radiopharmaceuticals, licensing expansions, and supplier alliances to mitigate supply chain risks. Differentiation is achieved through proprietary manufacturing technologies, tailored dosing options, and partnerships with diagnostic imaging centers. A persistent challenge is margin pressure from payer negotiations and commoditization of standard-dose products. Firms also face elevated costs for maintaining GMP compliance and navigating evolving nuclear medicine regulations, which favor larger, vertically integrated entities over smaller niche suppliers.

Mallinckrodt: Expanding regional footprint in Asia-Pacific through licensing agreements.

Bracco Imaging: Focused innovation pipeline for oncology-specific radiopharmaceuticals.

Lantheus Medical Imaging: Strengthening channel strength via hospital network partnerships.

Isotope Technologies: Reducing costs through in-house radionuclide production.

Bayer HealthCare: Leveraging OEM tie-ups for rapid market entry in emerging economies.

Guangzhou Jiuzhi: Adopting localized manufacturing to bypass import tariffs in Southeast Asia.

Market Ecosystem

The Sodium Iodide Injection ecosystem spans upstream raw material suppliers, midstream manufacturers and technology partners, and downstream healthcare providers. Value is generated through the production of radiopharmaceuticals for medical imaging, with compliance and precision critical to capturing value across the value chain analysis.

Raw material suppliers — provide sodium, iodine, and solvents for formulation

Contract manufacturers — produce injectable solutions under Good Manufacturing Practice (GMP) standards

Technology licensors — supply proprietary formulation and radiolabeling methodologies

OEMs — package and brand finished-dose injectables for clinical use

Distributors — manage cold chain logistics to healthcare facilities

Healthcare providers — administer injections for thyroid function diagnostics

Regulatory bodies — oversee safety, efficacy, and radioactive material handling protocols

Value flows are constrained by raw material availability, regulatory approvals, and technology licensing terms. Control points reside with regulators dictating market access and technology providers enabling scalable production. Dependency risks include input shortages and stringent compliance requirements, while high switching costs for end users reinforce long-term partnerships between manufacturers and healthcare institutions.

Recent Industry Insights

The Sodium Iodide Injection industry trends over the past 18 months reflect a dynamic market driven by advancements in nuclear medicine and diagnostic imaging. Key developments include strategic partnerships between radiopharmaceutical companies and healthcare providers to streamline supply chains for critical isotopes. Notably, a major merger in 2023 consolidated two leading producers, enhancing manufacturing capacity and global distribution networks. Innovations in product technology have emerged, with next-gen Sodium Iodide formulations offering improved stability and patient safety profiles. Regulatory shifts, including updated FDA guidelines on radiopharmaceutical labeling, have prompted manufacturers to revise compliance protocols. Additionally, rising demand for thyroid diagnostics and cancer therapies has spurred funding rounds for startups specializing in targeted radiotherapies. Enterprises are also prioritizing sustainability, investing in closed-loop production systems to reduce radioactive waste. These trends underscore a forward-looking industry poised for growth amid evolving healthcare demands.

Analyst Overview

The Sodium Iodide Injection market outlook remains cautiously optimistic, driven by increasing demand for nuclear medicine in diagnostic imaging and therapeutic applications. Market attractiveness is underscored by the growing prevalence of thyroid disorders and cancer, coupled with advancements in radiopharmaceuticals. However, regulatory constraints and production challenges for radioactive materials temper rapid expansion.

Competitive intensity is moderate, with a consolidated landscape dominated by established players leveraging proprietary manufacturing capabilities. New entrants face high barriers due to stringent compliance requirements and capital-intensive production. Strategic partnerships and geographic expansion are key differentiators in this segmented market.

The long-term outlook favors sustained growth, supported by innovation in targeted radionuclide therapies and improved dosimetry techniques. However, the innovation landscape remains incremental, with limited breakthroughs due to the specialized nature of radiopharmaceutical R&D. Supply chain resilience will be critical to address the demand–supply balance, as production of iodine-131 relies on a few global cyclotron facilities.

Key risk factors include regulatory scrutiny, fluctuating raw material availability, and the high cost of waste management for radioactive substances. Decision-makers must prioritize Sodium Iodide Injection market outlook strategies that enhance production efficiency while navigating evolving safety standards to mitigate these risks.

12 items

1. Executive Summary

2. Sodium Iodide Injection Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Sodium Iodide Injection Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Sodium Iodide Injection Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Sodium Iodide Injection Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Sodium Iodide Injection Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Sodium Iodide Injection Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Sodium Iodide Injection Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Sodium Iodide Injection Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Sodium Iodide Injection Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Sodium Iodide Injection Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Sodium Iodide Injection Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Sodium Iodide Injection Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Sodium Iodide Injection Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Sodium Iodide Injection Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Sodium Iodide Injection Market Competition by Key Manufacturers

9.1. Global Sodium Iodide Injection Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Sodium Iodide Injection: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Sodium Iodide Injection Market

Figure 4: Global Sodium Iodide Injection Market: Drivers

Figure 5: Global Sodium Iodide Injection Market: Challenges

Figure 6: Global Sodium Iodide Injection Market: Trends

Figure 7: Global Sodium Iodide Injection Market: Opportunity

Figure 8: Global Sodium Iodide Injection Market: Restraint

Figure 9: Global Sodium Iodide Injection Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Sodium Iodide Injection Market Value (USD Million) By Region

Figure 19: Global Sodium Iodide Injection Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Sodium Iodide Injection Market Value (USD Million) By Region

Figure 27: Global Sodium Iodide Injection Market Share (%) By: Regions (2032)

Figure 28: Global Sodium Iodide Injection Market Volume (K) By Region

Figure 29: Global Sodium Iodide Injection Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Sodium Iodide Injection Market Value (USD Million) By Region

Figure 37: Global Sodium Iodide Injection Market Share (%) By: Regions (2032)

Figure 38: Global Sodium Iodide Injection Market Volume (K) By Region

Figure 39: Global Sodium Iodide Injection Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

95 items

Table 1: Market Segmentation Analysis

Table 2: Global Sodium Iodide Injection Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Sodium Iodide Injection Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Sodium Iodide Injection Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Sodium Iodide Injection Market Value (USD Million) By Region

Table 14: Global Sodium Iodide Injection Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Sodium Iodide Injection Market Volume (K) By Region

Table 31: Global Sodium Iodide Injection Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Sodium Iodide Injection Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Sodium Iodide Injection Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Sodium Iodide Injection Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Global Market Value (USD Million) (2025-2032) By Application

Table 52: Global Market Share (%) By Application (2032)

Table 53: Global Market Value (USD Million) (2025-2032) By Types

Table 54: Global Market Share (%) By Types (2032)

Table 55: Global Market Volume (K) (2025-2032) By Application

Table 56: Global Market Share (%) By Application (2032)

Table 57: Global Market Volume (K) (2025-2032) By Types

Table 58: Global Market Share (%) By Types (2032)

Table 59: Global Sodium Iodide Injection Market Value (USD Million) By Region

Table 60: Global Sodium Iodide Injection Market Share (%) By Region (2025-2032)

Table 61: North America Market Value (USD Million) (2025-2032) By Country

Table 62: North America Market Value (USD Million) (2025-2032) By Application

Table 63: North America Market Value (USD Million) (2025-2032) By Types

Table 64: Europe Market Value (USD Million) (2025-2032) By Country

Table 65: Europe Market Value (USD Million) (2025-2032) By Application

Table 66: Europe Market Value (USD Million) (2025-2032) By Types

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 69: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 70: South America Market Value (USD Million) (2025-2032) By Country

Table 71: South America Market Value (USD Million) (2025-2032) By Application

Table 72: South America Market Value (USD Million) (2025-2032) By Types

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 75: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 76: Global Sodium Iodide Injection Market Volume (K) By Region

Table 77: Global Sodium Iodide Injection Market Share (%) By Region (2025-2032)

Table 78: North America Market Volume (K) (2025-2032) By Country

Table 79: North America Market Volume (K) (2025-2032) By Application

Table 80: North America Market Volume (K) (2025-2032) By Types

Table 81: Europe Market Volume (K) (2025-2032) By Country

Table 82: Europe Market Volume (K) (2025-2032) By Application

Table 83: Europe Market Volume (K) (2025-2032) By Types

Table 84: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 85: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 86: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 87: South America Market Volume (K) (2025-2032) By Country

Table 88: South America Market Volume (K) (2025-2032) By Application

Table 89: South America Market Volume (K) (2025-2032) By Types

Table 90: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 91: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 92: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 93: Research Programs/Design For This Report

Table 94: Key Data Information From Secondary Sources

Table 95: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Sodium Iodide Injection Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.30 billion
Revenue forecast in 2033	4.01 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Acuity Inc.; Cree Lighting USA LLC.; Samsung Electronics; Signify Holding; OSRAM GmbH; Savant Systems, Inc.; Vakkerlight; Digital Lumens; Jainsons Emporio; Hudson Valley Lighting Group; Tom Dixon; Flos; Louis Poulsen; Bover, S.L.; Vibia
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options